Found 7 matching trials
A Study Comparing MB02 and Avastin® in Subjects With Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) PHASE3 This is a multicenter, multinational, double-blind, 1:1 randomized, paralle...
Show More Learn More & Join Trial
To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer PHASE3 To demonstrate that CT-P16 is similar to EU-Approved Avastin in terms of ef...
Show More Location
Chung-Ang University Hospital
Learn More & Join Trial
To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin PHASE1 This study is a Phase 1 Randomized, Double-blind, Three-arm, Parallel Group...
Show More Location
Inje University Busan Paik Hospital
Learn More & Join Trial
A Pharmacokinetic Study Comparing MB02 And EU Avastin® In Healthy Male Volunteers PHASE1 A Randomised, Double Blind, Two-Arm, Single Dose, Parallel Phase I Study To...
Show More Location
SOUSEIKAI Hakata Clinic
Learn More & Join Trial
Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers PHASE1 Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Show More Location
Early Phase Clinical Unit (EPCU) PAREXEL International GmbH
Learn More & Join Trial
A Pharmacokinetic Study Comparing MB02 And US And EU Avastin® In Healthy Male Volunteers PHASE1 Randomized, double blind, parallel group, single dose, 3 arm study to inves...
Show More Location
PAREXEL International - Northwick Park Hospital
Learn More & Join Trial
Bioequivalence and Safety Study of Bevacizumab-biosimilar (RPH-001) Compared to Bevacizumab-innovator PHASE1 The purpose of this to assess pharmacokinetic bioequivalence between two be...
Show More Location
Multiple Locations
Learn More & Join Trial